These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Publisher Correction: A human monoclonal antibody blocking SARS-CoV-2 infection. Wang C; Li W; Drabek D; Okba NMA; van Haperen R; Osterhaus ADME; van Kuppeveld FJM; Haagmans BL; Grosveld F; Bosch BJ Nat Commun; 2020 May; 11(1):2511. PubMed ID: 32409714 [TBL] [Abstract][Full Text] [Related]
10. Publisher Correction: Targeting of temperate phages drives loss of type I CRISPR-Cas systems. Rollie C; Chevallereau A; Watson BNJ; Chyou TY; Fradet O; McLeod I; Fineran PC; Brown CM; Gandon S; Westra ER Nature; 2020 Mar; 579(7799):E10. PubMed ID: 32123354 [TBL] [Abstract][Full Text] [Related]
11. Publisher Correction: Manufacturing and preclinical validation of CAR T cells targeting ICAM-1 for advanced thyroid cancer therapy. Vedvyas Y; McCloskey JE; Yang Y; Min IM; Fahey TJ; Zarnegar R; Hsu YS; Hsu JM; van Basien K; Gaudet I; Law P; Kim NJ; von Hofe E; Jin MM Sci Rep; 2020 Jul; 10(1):12733. PubMed ID: 32719389 [TBL] [Abstract][Full Text] [Related]
12. Publisher Correction: Profiling the susceptibility of Pseudomonas aeruginosa strains from acute and chronic infections to cell-wall-targeting immune proteins. Torrens G; Barceló IM; Pérez-Gallego M; Escobar-Salom M; Tur-Gracia S; Munar-Bestard M; González-Nicolau MDM; Cabrera-Venegas YJ; Rigo-Rumbos EN; Cabot G; López-Causapé C; Rojo-Molinero E; Oliver A; Juan C Sci Rep; 2020 Mar; 10(1):4356. PubMed ID: 32132557 [TBL] [Abstract][Full Text] [Related]
13. Publisher Correction: Engineered CRISPR-Cas12a variants with increased activities and improved targeting ranges for gene, epigenetic and base editing. Kleinstiver BP; Sousa AA; Walton RT; Tak YE; Hsu JY; Clement K; Welch MM; Horng JE; Malagon-Lopez J; Scarfò I; Maus MV; Pinello L; Aryee MJ; Joung JK Nat Biotechnol; 2020 Jul; 38(7):901. PubMed ID: 32541959 [TBL] [Abstract][Full Text] [Related]
14. Publisher Correction: Optimal Mass Transport with Lagrangian Workflow Reveals Advective and Diffusion Driven Solute Transport in the Glymphatic System. Koundal S; Elkin R; Nadeem S; Xue Y; Constantinou S; Sanggaard S; Liu X; Monte B; Xu F; Nostrand WV; Nedergaard M; Lee H; Wardlaw J; Benveniste H; Tannenbaum A Sci Rep; 2020 Feb; 10(1):3934. PubMed ID: 32107453 [TBL] [Abstract][Full Text] [Related]
15. Publisher Correction: Drug pipeline 1Q19. DeFrancesco L Nat Biotechnol; 2019 Aug; 37(8):962. PubMed ID: 31332327 [TBL] [Abstract][Full Text] [Related]
16. Publisher Correction: A glycoprotein B-neutralizing antibody structure at 2.8 Å uncovers a critical domain for herpesvirus fusion initiation. Oliver SL; Xing Y; Chen DH; Roh SH; Pintilie GD; Bushnell DA; Sommer MH; Yang E; Carfi A; Chiu W; Arvin AM Nat Commun; 2020 Aug; 11(1):4398. PubMed ID: 32859924 [TBL] [Abstract][Full Text] [Related]
17. Publisher Correction: Breast cancer drug approvals by the US FDA from 1949 to 2018. Leo CP; Leo C; Szucs TD Nat Rev Drug Discov; 2020 Apr; 19(4):291. PubMed ID: 31937949 [TBL] [Abstract][Full Text] [Related]
18. Publisher Correction: Programmable multistage drug delivery to lymph nodes. Schudel A; Chapman AP; Yau MK; Higginson CJ; Francis DM; Manspeaker MP; Avecilla ARC; Rohner NA; Finn MG; Thomas SN Nat Nanotechnol; 2020 Aug; 15(8):724. PubMed ID: 32632322 [TBL] [Abstract][Full Text] [Related]
19. Correction: Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer. Gao M; Lin M; Moffitt RA; Salazar MA; Park J; Vacirca J; Huang C; Shroyer KR; Choi M; Georgakis GV; Sasson AR; Talamini MA; Kim J Br J Cancer; 2020 Aug; 123(3):495. PubMed ID: 32393850 [TBL] [Abstract][Full Text] [Related]